Eye scan study using special imaging for blood-vessel disease
Part of Eyes & vision, Heart & circulation, Hormones & metabolism clinical trials.
This study uses a detailed eye scan (optical coherence tomography angiography) to look at how blood vessels in the retina are affected. It may help researchers better understand retinal vascular diseases, though some people will be excluded for safety or image-quality reasons.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You must be able to give informed consent (or via an appropriate process) and follow study instructions
- You must be able to sit still enough for clear imaging (no major movement during scans)
- You must not have very low scan quality or blurry images (signal strength must be at least 7)
- You should not have certain eye conditions (including glaucoma or age-related macular degeneration) or other major eye diseases
- You should not have major medical conditions such as heart disease or thyroid disease; and for control participants, no diabetes or hypertension
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special eye imaging test called OCT angiography to look at tiny blood vessels in the back of the eye. It aims to understand changes caused by diabetic retinopathy, which could help improve how we monitor and treat this condition.
This study uses a special eye scan to take detailed pictures of the back of the eye in people with various retinal conditions. It may help doctors better understand and manage these diseases.
This trial tests whether a special eye scan (OCT) can help guide eye surgery during the operation. It may improve how surgeons see and target the exact eye structures they need to treat.
This study looks for specific eye findings (“biomarkers”) in people with type 2 diabetes using eye imaging. It may help researchers better understand diabetic retinopathy and how to detect it earlier or more accurately.
This trial uses a special eye scanner to look at eye diseases. It might help doctors see eye problems more clearly.
This study uses a special eye scan (OCTA) to check the health of tiny blood vessels in the back of the eye. It may help doctors understand small vessel disease in the brain and find easier ways to monitor it.
Hear when a new Diabetic Retinopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.